	The novel coronavirus pandemic has presented the global pharma industry with a double challenge: to develop potential treatments and preventative vaccines, and continue to meet the existing needs of healthcare providers and patients, all at a time when travel bans are in place and work must be handled remotely or with special precautions.

	In the initial weeks of the present emergency, bio/pharma companies, contract service providers, and regulatory authorities have taken measures to ensure continued operations. While addressing the challenges of today, the bio/pharma industry also needs to look ahead to what may be new operating and supply chain conditions for the coming months or years.

	During a special online presentation-broadcast on April 28, 2020 at 11 am EDT-the editors of 

 interview experts who will discuss approaches that are helping manufacturers surmount these challenges, while technology providers and representatives from different facets of the pharma industry-regulatory, contract testing and manufacturing, quality control, and distribution-will share best practices that are enabling them to meet the pandemic’s challenges head on.

	Topics to be discussed in this Editors’ Series event, 

Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times

		Testing guidance for new and existing drugs

		Data security, data integrity, and remote data access and collaboration.

		Steve Goldman, consultant, Steve Goldman Associates

		Susan Schniepp, distinguished fellow, Regulatory Compliance Associates

		Jaap Venema, executive vice president and chief science officer, United States Pharmacopeia

		Mary Blenn, vice-president global supply chain, Cytiva

		Angelo Stracquatanio, CEO, apprentice.io

		Lisia Marina Scholz Dias, lead application engineer, Applied Materials

 magazines, in conjunction with the INTERPHEX trade show.

COVID-19 Update

Industry News

PharmTech News

Quality Systems

Regulatory/GMP Compliance

Experts to discuss strategies for ensuring supply of quality drug products during a pandemic in April 28 online event.